Showing results (11-20 of 564) with videos related to

Sort By:
Pageof 57
Tissue Antigens|April 1, 1997
Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexyE Mignot, A Kimura, A Lattermann, et al.
The Journal of Clinical Investigation|September 1, 1988
Role of central alpha-1 adrenoceptors in canine narcolepsyE Mignot, C Guilleminault, S Bowersox, et al.
Brain Research|March 15, 1988
Effect of alpha 1-adrenoceptors blockade with prazosin in canine narcolepsyE Mignot, C Guilleminault, S Bowersox, et al.
European Journal of Pharmacology|November 19, 1991
Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleepA Renaud, S Nishino, W C Dement, et al.
Sleep|December 1, 1994
An immunoglobulin switchlike sequence is linked with canine narcolepsyE Mignot, R A Bell, C Rattazzi, et al.
Human Immunology|March 1, 1995
Extensive polymorphism of a (CA)n microsatellite located in the HLA-DQA1/DQB1 class II regionC Macaubas, J Hallmayer, J Kalil, et al.
Brain Research|October 23, 1989
Canine narcolepsy is associated with an elevated number of alpha 2-receptors in the locus coeruleusB Fruhstorfer, E Mignot, S Bowersox, et al.
Psychopharmacology|January 1, 1993
Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancersE Mignot, A Renaud, S Nishino, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsyS Nishino, B Fruhstorfer, J Arrigoni, et al.
Sleep|February 16, 1999
Validation of a cataplexy questionnaire in 983 sleep-disorders patientsS Anic-Labat, C Guilleminault, H C Kraemer, et al.
Pageof 57